ArticleJournal of hepatocellular carcinoma2023

Population Sensitive to Lenvatinib Plus Anti-PD-1 for Unresectable Hepatocellular Carcinoma Infected with Hepatitis B Virus.

Xiujuan Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.